Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?

Journal of Affective Disorders

Volumn 119, Issue 1-3, 2009, Pages 181-185

  Capuron, Lucile ^a   Fornwalt, Fiona B ^b   Knight, Bettina T ^b   Harvey, Philip D ^b   Ninan, Philip T ^c   Miller, Andrew H ^b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PFIZER INC   (United States)

Author keywords

Cytokine; Depression; Guilt; Interferon alpha; Psychomotor slowing

Indexed keywords

ALPHA INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ADULT; AGED; AGITATION; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; GUILT; HAMILTON SCALE; HUMAN; HYPOCHONDRIASIS; INNATE IMMUNITY; INSOMNIA; MAJOR DEPRESSION; MALE; MELANOMA; MENTAL CONCENTRATION; MOTOR ACTIVITY; MUSCLE TONE; PHYSICAL DISABILITY; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; SPEECH DISORDER; SUICIDAL IDEATION; WEIGHT REDUCTION; WORK DISABILITY;

ADULT; AGED; DEPRESSIVE DISORDER, MAJOR; FEMALE; GUILT; HUMANS; INTERFERON-ALPHA; MALE; MELANOMA; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; WEIGHT LOSS;

EID: 70349734652     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.02.017     Document Type: Article

References (25)

1. Anisman H., Merali Z., Poulter M.O., and Hayley S. Cytokines as a precipitant of depressive illness: animal and human studies. Curr. Pharm. Des. 11 (2005) 963-972
2. Association A.P. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition (1994), American Psychiatric Association, Washington, DC
3. Bair M.J., Robinson R.L., Katon W., and Kroenke K. Depression and pain comorbidity: a literature review. Arch. Intern. Med. 163 (2003) 2433-2445
4. Brydon L., Harrison N.A., Walker C., Steptoe A., and Critchley H.D. Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol. Psychiatry 63 (2008) 1022-1029
5. Capuron L., and Miller A.H. Cytokines and psychopathology: lessons from interferon-alpha. Biol. Psychiatry 56 (2004) 819-824
6. Capuron L., Ravaud A., and Dantzer R. Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients. Psychosom. Med. 63 (2001) 376-386
7. Capuron L., Gumnick J.F., Musselman D.L., Lawson D.H., Reemsnyder A., Nemeroff C.B., and Miller A.H. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26 (2002) 643-652
8. Capuron L., Pagnoni G., Demetrashvili M.F., Lawson D.H., Fornwalt F.B., Woolwine B., Berns G.S., Nemeroff C.B., and Miller A.H. Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology 32 (2007) 2384-2392
9. Cohen J.D. Statistical Power Analysis for the Behavioral Sciences. Second Edition (1988), Lawrence Erlbaum Associates, Hillsdale, N.J.
10. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., and Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev., Neurosci. 9 (2008) 46-56
11. Felger J.C., Alagbe O., Hu F., Mook D., Freeman A.A., Sanchez M.M., Kalin N.H., Ratti E., Nemeroff C.B., and Miller A.H. Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression. Biol. Psychiatry 62 (2007) 1324-1333
12. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
13. Juengling F.D., Ebert D., Gut O., Engelbrecht M.A., Rasenack J., Nitzsche E.U., Bauer J., and Lieb K. Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Psychopharmacology (Berl). 152 (2000) 383-389
14. Kendler K.S., Myers J., and Zisook S. Does bereavement-related major depression differ from major depression associated with other stressful life events?. Am. J. Psychiatry 165 (2008) 1449-1455
15. Kroenke K., Jackson J.L., and Chamberlin J. Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors and outcome. Am. J. Med. 103 (1997) 339-347
16. Majer M., Welberg L.A., Capuron L., Pagnoni G., Raison C.L., and Miller A.H. IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. Brain Behav. Immun. 22 (2008) 870-880
17. Muller N., Schwarz M.J., Dehning S., Douhe A., Cerovecki A., Goldstein-Muller B., Spellmann I., Hetzel G., Maino K., Kleindienst N., Moller H.J., Arolt V., and Riedel M. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol. Psychiatry 11 (2006) 680-684
18. Musselman D.L., Lawson D.H., Gumnick J.F., Manatunga A.K., Penna S., Goodkin R.S., Greiner K., Nemeroff C.B., and Miller A.H. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N. Engl. J. Med. 344 (2001) 961-966
19. Plata-Salaman C.R. Anorexia during acute and chronic disease. Nutrition 12 (1996) 69-78
20. Plata-Salaman C.R. Cytokines and anorexia: a brief overview. Semin. Oncol. 25 (1998) 64-72
21. Raison C.L., Capuron L., and Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27 (2006) 24-31
22. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., and Pollmacher T. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 58 (2001) 445-452
23. Simon G.E., VonKorff M., Piccinelli M., Fullerton C., and Ormel J. An international study of the relation between somatic symptoms and depression. N. Engl. J. Med. 341 (1999) 1329-1335
24. Tyring S., Gottlieb A., Papp K., Gordon K., Leonardi C., Wang A., Lalla D., Woolley M., Jahreis A., Zitnik R., Cella D., and Krishnan R. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367 (2006) 29-35
25. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 711 (1996) 163-174